Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?

Kunihiro Asanuma(Mie University), Akihiro Sudo(Mie University)

BMC Cancer

October 18, 2022

10.1186/s12885-022-10106-4

Cited by 9

Related Papers

Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways

|Cancers|2023|9

Cervical schwannoma in the early stage of pregnancy: a case report

|BMC Surgery|2020|7

Release of Exosomal PD-L1 in Bone and Soft Tissue Sarcomas and Its Relationship to Radiotherapy

|Cancers|2024|2

Pathological Features of Reinnervated Skeletal Muscles Following Crush Injury of the Sciatic Nerve in Ob/ob Mice

|Research Square|2020|0

Cryoablation for malignant bone and soft tissue tumors and histological assessment of ablated tumors

|Research Square|2024|0